Nakada Yasuki, Kawakami Rika, Matsui Masaru, Ueda Tomoya, Nakano Tomoya, Takitsume Akihiro, Nakagawa Hitoshi, Nishida Taku, Onoue Kenji, Soeda Tsunenari, Okayama Satoshi, Watanabe Makoto, Kawata Hiroyuki, Okura Hiroyuki, Saito Yoshihiko
First Department of Internal Medicine, Nara Medical University, Kashihara Nara, Japan.
First Department of Internal Medicine, Nara Medical University, Kashihara Nara, Japan
J Am Heart Assoc. 2017 May 18;6(5):e004582. doi: 10.1161/JAHA.116.004582.
Urinary neutrophil gelatinase-associated lipocalin (U-NGAL) is an early predictor of acute kidney injury and adverse events in various diseases; however, in acute decompensated heart failure patients, its significance remains poorly understood. This study aimed to investigate the prognostic value of U-NGAL on the first day of admission for the occurrence of acute kidney injury and long-term outcomes in acute decompensated heart failure patients.
We studied 260 acute decompensated heart failure patients admitted to our department between 2011 and 2014 by measuring U-NGAL in 24-hour urine samples collected on the first day of admission. Primary end points were all-cause death, cardiovascular death, and heart failure admission. Patients were divided into 2 groups according to their median U-NGAL levels (32.5 μg/gCr). The high-U-NGAL group had a significantly higher occurrence of acute kidney injury during hospitalization than the low-U-NGAL group (=0.0012). Kaplan-Meier analysis revealed that the high-U-NGAL group exhibited a worse prognosis than the low-U-NGAL group in all-cause death (hazard ratio 2.07; 95%CI 1.38-3.12, =0.0004), cardiovascular death (hazard ratio 2.29; 95%CI 1.28-4.24, =0.0052), and heart failure admission (hazard ratio 1.77; 95%CI 1.13-2.77, =0.0119). The addition of U-NGAL to the estimated glomerular filtration rate significantly improved the predictive accuracy of all-cause mortality (=0.0083).
In acute decompensated heart failure patients, an elevated U-NGAL level on the first day of admission was related to the development of clinical acute kidney injury and independently associated with poor prognosis.
尿中性粒细胞明胶酶相关脂质运载蛋白(U-NGAL)是各种疾病中急性肾损伤和不良事件的早期预测指标;然而,在急性失代偿性心力衰竭患者中,其意义仍知之甚少。本研究旨在探讨入院第一天U-NGAL对急性失代偿性心力衰竭患者发生急性肾损伤及长期预后的预测价值。
我们研究了2011年至2014年间入住我科的260例急性失代偿性心力衰竭患者,通过检测入院第一天采集的24小时尿液样本中的U-NGAL。主要终点为全因死亡、心血管死亡和心力衰竭再入院。根据患者U-NGAL水平中位数(32.5μg/gCr)将患者分为两组。高U-NGAL组住院期间急性肾损伤的发生率显著高于低U-NGAL组(P=0.0012)。Kaplan-Meier分析显示,高U-NGAL组在全因死亡(风险比2.07;95%CI 1.38-3.12,P=0.0004)、心血管死亡(风险比2.29;95%CI 1.28-4.24,P=0.0052)和心力衰竭再入院(风险比1.77;95%CI 1.13-2.77,P=0.0119)方面的预后均较低U-NGAL组差。将U-NGAL加入估计肾小球滤过率可显著提高全因死亡率的预测准确性(P=0.0083)。
在急性失代偿性心力衰竭患者中,入院第一天U-NGAL水平升高与临床急性肾损伤的发生有关,并独立与不良预后相关。